Clinical trials
Recruiting Phase 2 Non-Muscle Invasive Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| BLATAM | 1 |
| Blokhin's Russian Cancer Research Center | 1 |
| CHU de Quebec-Universite Laval | 1 |
| Ekaterina Laukhtina | 1 |
| John Sfakianos | 1 |
| Lepu Biopharma Co., Ltd. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Michael A. O'Donnell | 1 |
| Protara Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 18 |
| Urinary Bladder Neoplasms | 5 |
| Carcinoma in Situ | 4 |
| Neoplasms | 3 |
| Carcinoma, Transitional Cell | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.